Document Overview
Regulatory filing submitted to BSE Limited on August 29, 2018, containing unaudited financial results for the quarter ended June 30, 2018, with limited review report as required under SEBI Listing Obligations and Disclosure Requirements Regulation 33(3)(a).
Financial Results Summary
- Net Loss for Q1 FY19 (June 30, 2018): ₹(3,827.00)
- Total Income from operations: ₹0.00
- Total Expenses: ₹(3,827.00)
- Employee benefits expense: ₹(5,000.00)
- Other expenses: ₹(3,827.00)
- Profit before tax: ₹(3,827.00)
- Tax Expense: ₹0.00 (provision to be made at year-end)
- Paid-up equity share capital: ₹46,132,000.00 (Face Value ₹10 per share)
Comparative Performance
- Previous quarter (March 31, 2018): Net Loss ₹(111,664.00)
- Corresponding quarter previous year (June 30, 2017): Net Loss ₹(31,964.00)
- Full year previous year (March 31, 2018): Net Loss ₹(179,855.76)
Accounting Standards and Compliance
- Financial results prepared in accordance with Companies (Indian Accounting Standards) Rules, 2015 (Ind AS)
- Company adopted Ind AS effective April 1, 2017, with transition date of April 1, 2016
- Statement does not include Ind AS compliant results for preceding quarter and previous year ended March 31, 2017 as not mandatory per SEBI circular dated July 5, 2016
- Limited review conducted by statutory auditors P.D. Agrawal & Co. (Firm Registration No. 001049C)
Review and Approval Process
- Results reviewed by Audit Committee and approved by Board of Directors at meeting held on July 29, 2018
- Limited review report dated July 25, 2018, issued by P.D. Agrawal & Co., Chartered Accountants
- Auditors confirmed nothing came to their attention suggesting material misstatement in the financial results
Notes and Qualifications
- Provision for Income Tax and Deferred Tax, if any, will be made at the end of the year
- Figures of previous period quarter have been regrouped wherever necessary
- Comparative figures including reconciliation to Total Comprehensive Income for quarter ended June 2018 were furnished by Management and not reviewed by auditors